{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"VolitionRX Limited"},"Symbol":{"label":"Symbol","value":"VNRX"},"Address":{"label":"Address","value":"13215 BEE CAVE PARKWAY,SUITE 125, GALLERIA OAKS B SUITE 110, AUSTIN, Texas, 78738, United States"},"Phone":{"label":"Phone","value":"+1 646 650-1351"},"Industry":{"label":"Industry","value":"Biotechnology: In Vitro & In Vivo Diagnostic Substances"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"Asia"},"CompanyDescription":{"label":"Company Description","value":"VolitionRX Ltd is a us-based multi-national life sciences company. It is engaged in developing easy to use blood-based tests to accurately diagnose a range of cancers. The development pipeline includes assays to be used for symptomatic patients or asymptomatic populations. The company has developed more than 30 blood-based assays to detect specific biomarkers. It also develops Nucleosomics tests for several major cancers including CRC, pancreatic, lung and aggressive prostate. In addition, the company engages in the process of developing HyperGenomics tissue and blood-based tests to determine disease subtype following initial diagnosis and to help decide the appropriate therapy."},"CompanyUrl":{"label":"Company Url","value":"https://www.volition.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Cameron John Reynolds","title":"President, Chief Executive Officer & Director"},{"name":"Gaetan Michel","title":"Chief Operating Officer"},{"name":"Jacob Vincent Micallef","title":"Chief Scientific Officer"},{"name":"Mark Edward Eccleston","title":"Chief Technology Officer"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}